Waters Corp. WAT

NYS: WAT | ISIN: US9418481035 8/06/2026

363,34 USD (-0,55%)

(-0,55%) 8/06/2026

Grafiek Waters Corp.

Grafiek Waters Corp.

1 dag1d -0,55%
1 week1w -2,31%
1 maand1m 4,39%
3 maanden3m 18,87%
6 maanden6m -5,91%
1 jaar1j 4,31%
5 jaar5j 10,77%

Waters Corp. in het nieuws

Toon enkel gratis nieuws

8 juni 2026 · Waters Launches Industry-First Reversed-Phase Bioseparation Columns to Deliver Up to 3x Faster GLP-1 Characterization and 2x Faster LNP Component Analysis · Persbericht

3 juni 2026 · Waters Announces FDA 510(k) Clearance of BD BACTEC FXI Culture System, Enabling Broader Access to Bloodstream Infection Diagnostics · Persbericht

1 juni 2026 · Waters Unveils Cyclic IMS P20 MS: The New Benchmark in Structural and Spatial Omics · Persbericht

1 juni 2026 · Waters Introduces Unrivaled Sensitivity and Speed to Benchtop HRMS with Xevo MRT P10 MS, Accelerating Multiomics Research · Persbericht

18 mei 2026 · Waters Corporation to Present at the Jefferies Global Healthcare Conference · Persbericht

5 mei 2026 · Waters Corporation (NYSE: WAT) Reports First Quarter 2026 Financial Results · Persbericht

20 april 2026 · Waters Corporation Schedules First Quarter 2026 Earnings Conference Call · Persbericht

14 april 2026 · Waters Debuts Industry-First Extended-Range MALS Detector for UHPLC/UPLC, Powering Rapid Characterization of Large Molecules · Persbericht

8 april 2026 · Waters Announces FDA Clearance of the Most Comprehensive At-Home Cervical Cancer Screening Tool, the Onclarity HPV Self-Collection Kit and FDA-Approved HPV Assay · Persbericht

18 maart 2026 · Waters Prices Offering of Senior Notes · Persbericht

Profiel Waters Corp.

Gezondheidstechnologie

Medische Specialiteiten

Productie van analytische laboratoriuminstrumenten

Website: www.waters.com/nextgen/us/en.html

Hoofdzetel: Milford, Massachusetts Verenigde Staten

Mijn selecties

Je selectie is nog leeg.

Voeg nu effecten toe